News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

FDA approves Ocrevus Zunovo for relapsing and primary progressive MS

September 16, 2024

Treatment has the potential to expand options to centers without IV infrastructure or with IV constraints.
Learn more

Study provides insights into how brain regenerates lost myelin

September 12, 2024

The findings could have important implications for the ongoing effort to develop new and improved therapies for the treatment of demyelinating diseases.
Learn more

Study reveals molecular mechanism behind MS

August 30, 2024

The findings suggest a new target for a universal treatment for human autoimmune disease.
Learn more

Human stem cell models point to glia as key players in MS

August 29, 2024

Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments.
Learn more

Study suggests MS may protect against Alzheimer’s disease

August 27, 2024

The findings support observations that Alzheimer’s appeared to be less likely to develop among those with MS.
Learn more

COVID-19 vaccine not tied to MS relapse

August 16, 2024

The absence of such a risk is encouraging for people with MS so they may receive booster shots when needed.
Learn more

Study reveals unique histone tag in adult oligodendrocyte progenitor cells

August 13, 2024

The findings may help advance development of new therapies for neurodegenerative diseases such as multiple sclerosis.
Learn more

Current challenges evaluated for measuring and treating fatigue in MS

August 09, 2024

New study sheds light on defining, assessing, and addressing MS-related fatigue
Learn more

Researchers seek participants for MS study

August 07, 2024

Program to test effects of exercise on physical and brain function.
Learn more

FDA approves Ocrevus Zunovo for relapsing and primary progressive MS

September 16, 2024

Treatment has the potential to expand options to centers without IV infrastructure or with IV constraints.
Learn more

Study provides insights into how brain regenerates lost myelin

September 12, 2024

The findings could have important implications for the ongoing effort to develop new and improved therapies for the treatment of demyelinating diseases.
Learn more

Study reveals molecular mechanism behind MS

August 30, 2024

The findings suggest a new target for a universal treatment for human autoimmune disease.
Learn more

Human stem cell models point to glia as key players in MS

August 29, 2024

Largest collection of patient stem cell models of multiple sclerosis to date uncovers novel disease insights and opens the door for new treatments.
Learn more

Study suggests MS may protect against Alzheimer’s disease

August 27, 2024

The findings support observations that Alzheimer’s appeared to be less likely to develop among those with MS.
Learn more

COVID-19 vaccine not tied to MS relapse

August 16, 2024

The absence of such a risk is encouraging for people with MS so they may receive booster shots when needed.
Learn more

Study reveals unique histone tag in adult oligodendrocyte progenitor cells

August 13, 2024

The findings may help advance development of new therapies for neurodegenerative diseases such as multiple sclerosis.
Learn more

Current challenges evaluated for measuring and treating fatigue in MS

August 09, 2024

New study sheds light on defining, assessing, and addressing MS-related fatigue
Learn more

Researchers seek participants for MS study

August 07, 2024

Program to test effects of exercise on physical and brain function.
Learn more

Researchers: Machine learning models may enhance planning for people with MS

August 02, 2024

The study found the history of disability progression was more predictive for future disability progression than treatment or relapse history.
Learn more

New therapeutic target offers a promising pathway for MS treatment

July 29, 2024

Researchers find that blocking an overproduced channel protein may improve symptoms in an animal model of MS.
Learn more

Study finds MS medication safe, effective across racial, ethnic groups

July 22, 2024

The researchers examined the efficacy and safety of ofatumumab in diverse populations, finding that overall, the drug was effective and safe across racial and ethnic groups.
Learn more

Study shows promising diagnosis of MS from images of the eye

July 19, 2024

What sets this approach apart is its ability to detect subtle changes in the eye that are often indicative of MS.
Learn more

Parental smoking increases MS risk, study suggests

July 17, 2024

The authors believe future research should continue to explore MS risk factors, but also patient prognosis. Association with parental smoking needs to be investigated further.
Learn more

Pilot study shows promise for remote cognitive rehabilitation for MS

July 02, 2024

Researchers noted that delivering therapy to individuals at home is not only convenient, but also expands access to cognitive rehabilitation designed to improve how individuals function in their daily lives.
Learn more

New assessment offers improved screening for risks, decline in MS patients

June 27, 2024

This assessment may improve clinical screening for mobility impairments, fall risk, and cognitive decline in individuals with MS.
Learn more

Study to explore effects of stigma, discrimination on mental health

June 21, 2024

Harvard research project seeks participants
Learn more

Interactive learning program increases MS preparedness

June 17, 2024

Implementing a hybrid clinical simulation program helps improve speech-language pathology graduate student preparedness in caring for people with MS.
Learn more


Show More News